Regional Health investor Radoff adds to stake
REGIONAL HEALTH PROPERTIES, INC investor Bradley L. Radoff and The Radoff Family Foundation reported multiple open-market trades in Common Stock and Series D Preferred Stock between April 13 and June 15, 2026.
Rhea-AI Filing Summary
REGIONAL HEALTH PROPERTIES, INC investor Bradley L. Radoff and The Radoff Family Foundation reported multiple open-market trades in Common Stock and Series D Preferred Stock between April 13 and June 15, 2026. Across these securities they bought 16,020 shares and sold 5,100 shares, a net increase of 10,920 shares. Many shares are held by the Radoff Family Foundation, for which Mr. Radoff disclaims any pecuniary interest. The 8% cumulative Series D Preferred is convertible into Common Stock at 1.1330 shares for every three preferred shares, subject to a 19.99% beneficial ownership cap and has no expiration date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,920 shares
Net Buy
11 txns
Insider
Radoff Bradley Louis, Radoff Family Foundation
Role
10% Owner | Insider
Bought
16,020 shs ($23K)
Sold
5,100 shs ($6K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 100 | $1.06 | $106.00 |
| Sale | Common Stock F1, F2 | 5,000 | $1.15 | $6K |
| Purchase | Common Stock F1, F2 | 1,009 | $1.4241 | $1K |
| Purchase | Common Stock F1, F2 | 1,000 | $1.40 | $1K |
| Purchase | Common Stock F1 | 2,000 | $1.43 | $3K |
| Purchase | Common Stock F1, F2 | 500 | $1.40 | $700.00 |
| Purchase | Series D Preferred Stock F1, F3 | 1,000 | $2.2009 | $2K |
| Purchase | Series D Preferred Stock F1, F3 | 600 | $2.1291 | $1K |
| Purchase | Common Stock F1 | 3,511 | $1.2969 | $5K |
| Purchase | Common Stock F1 | 6,300 | $1.2896 | $8K |
| Purchase | Common Stock F1, F2 | 100 | $1.21 | $121.00 |
Holdings After Transaction:
Series D Preferred Stock — 171,263 contracts (Direct);
Common Stock — 220,737 shares (Direct);
Common Stock — 105,900 shares (Indirect, By The Radoff Family Foundation)
Footnotes (3)
- F1. This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F2. Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.
- F3. The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.
Key Figures
Total shares purchased: 16,020 shares
Total shares sold: 5,100 shares
Net shares acquired: 10,920 shares
+5 more
8 metrics
Total shares purchased
16,020 shares
Aggregate Common Stock and Series D Preferred purchases reported between April 13 and June 15, 2026
Total shares sold
5,100 shares
Aggregate Common Stock sales reported on June 5 and June 15, 2026
Net shares acquired
10,920 shares
Difference between reported purchases and sales across all securities in this Form 4
Largest common stock purchase
6,300 shares at $1.2896 per share
Direct Common Stock purchase on April 13, 2026
Series D Preferred purchase
1,000 shares at $2.2009 per share
Direct Series D Preferred Stock purchase on April 15, 2026
Series D Preferred purchase
600 shares at $2.1291 per share
Direct Series D Preferred Stock purchase on April 14, 2026
Series D conversion ratio
1.1330 shares of Common Stock for every three shares of Series D Preferred Stock
Conversion terms for Series D Preferred Stock in the articles of amendment
Beneficial ownership cap
19.99% of Common Stock outstanding
Maximum beneficial ownership allowed post-conversion for the reporting persons
Key Terms
Section 13(d) group, pecuniary interest, 8% Cumulative Convertible Redeemable Participating Preferred Shares, beneficially own
4 terms
Section 13(d) group regulatory
"may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10%"
pecuniary interest financial
"disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein"
beneficially own regulatory
"would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider trades were reported for RHEP by Bradley L. Radoff and the Radoff Family Foundation?
The reporting group recorded nine purchases and two sales in REGIONAL HEALTH PROPERTIES, INC securities, buying 16,020 shares and selling 5,100 shares between April 13 and June 15, 2026, for a net acquisition of 10,920 shares across common and Series D Preferred.
At what prices did the RHEP insider trades occur?
Common Stock trades ranged from about $1.06 to $1.43 per share, including a 5,000‑share sale at $1.15 and a 6,300‑share purchase at $1.2896. Series D Preferred purchases were reported at $2.1291 and $2.2009 per share.
What are the key terms of RHEP’s Series D Preferred Stock held by the reporting persons?
The Series D is an 8% Cumulative Convertible Redeemable Participating Preferred security, convertible any time into Common Stock at 1.1330 shares for every three preferred shares. Conversion is limited so the reporting group cannot exceed 19.99% beneficial ownership; the security has no expiration date.
Were the recent RHEP insider trades under a Rule 10b5-1 trading plan?
The Form 4’s Rule 10b5‑1 checkbox is not marked, indicating these trades are not being affirmatively reported as made under a Rule 10b5‑1 trading plan. No footnote describes any pre-arranged trading plan for the disclosed transactions.
How significant is the ownership position referenced in the RHEP Form 4?
The reporting persons may be deemed part of a Section 13(d) group that collectively beneficially owns more than 10% of RHEP’s outstanding Common Stock. They expressly disclaim beneficial ownership of reported securities except to the extent of any pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
